Previous Article | Next Article ![]()
Applied and Environmental Microbiology, July 2004, p. 3968-3972, Vol. 70, No. 7
0099-2240/04/$08.00+0 DOI: 10.1128/AEM.70.7.3968-3972.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Molecular Biology Division, National Institute of Fisheries Science, Fukuura, Kanazawa, Yokohama, Kanagawa 236-8648,1 Department of Biological Production and Environmental Science, Miyazaki University, Miyazaki 889-2192, Japan2
Received 1 February 2004/ Accepted 16 March 2004
|
|
|---|
|
|
|---|
In a previous study, some F. psychrophilum isolates from Danish rivers and hatcheries were found to be resistant to oxolinic acid (OXA) (3). In Japan at present, OXA is one of the antimicrobial agents licensed for wide use in aquaculture, and F. psychrophilum isolates from diseased fishes were often reported to be resistant to OXA (6). In gram-negative bacteria, resistance to quinolones most often corresponds to specific amino acid variations in a portion of the A subunit of DNA gyrase (GyrA) referred to as the quinolone resistance-determining region (QRDR) (18). We suspected that a similar mechanism was responsible for natural resistance to quinolones in F. psychrophilum isolates. In this study, to verify this hypothesis, we determined patterns of susceptibility to quinolones, OXA, and nalidixic acid (NA) and sequences of the partial gyrA region, including the QRDR, in 27 F. psychrophilum clinical isolates.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Susceptibilities of 27 F. psychrophilum isolates and mutation of GyrA
|
DNA extraction.
Total genomic DNA was prepared from individual strains according to the methods used in previous studies (7, 17). Briefly, one loopful of bacterial pellet was mixed with 300 µl of 5% Chelex100 (Sigma) and incubated at 55°C for 30 min. Following mixing by vortexing at high speed for 5 to 10 s, the mixture was boiled for 20 min and then centrifuged for 10 min at 10,000 x g. Without further purification, an aliquot of the supernatant containing DNA was used as a template for PCR amplification.
PCR amplification.
A degenerate universal primer pair, gyrAF and gyrAR (10), and a specific primer pair for the gyrA gene of F. psychrophilum, GYRA-FP1F and GYRA-FP1R, were used. The oligonucleotide sequences of gyrAF, gyrAR, GYRA-FP1F, and GYRA-FP1R were 5' GAYGGNYTNAARCCNGTNCA 3', 5' GCCATNCCNACNGCDATNCC 3', 5' GAAACCGGTGCACAGAAGG 3', and 5' CCTGTGGCTCCGTTTATTAA 3', respectively. PCR amplification was performed in a total reaction volume of 10 µl with a Techgene thermal cycler (Techne, Cambridge, United Kingdom). The reaction mixture contained 2 µl of template DNA, 0.1 nmol of each deoxynucleoside triphosphate, 10 pmol of each primer, and 0.5 U of Taq DNA polymerase (Bioneer, Daejeon, Korea). The following temperature profile was used for the amplification: preheating at 94°C for 5 min; 30 cycles of denaturation at 94°C for 30 s, annealing at 48 (gyrAF and gyrAR) or 56°C (GYRA-FP1F and GYRA-FP1R) for 30 s, and extension at 72°C for 90 s; and a final extension at 72°C for 5 min.
Cloning and sequencing of PCR products.
PCR products from three F. psychrophilum isolates (NCIMB1947, FPC814, and FPC840) with the universal primer pair (gyrAF and gyrAR) and PCR products from all F. psychrophilum isolates with the specific primer pair (GYRA-FP1F and GYRA-FP1R) were ligated with the pGEM-T vector (Promega, Madison, Wis.). For the ligation, T4 DNA ligase (Fermentas, Vilnius, Lithuania) was used, and the ligated clones were transformed into the competent E. coli strain EC100 (Epicentre, Madison, Wis.). Sequencing was performed with a CEQ DTCS Quick Start kit in a CEQ 2000 XL DNA analysis system (Beckman Coulter, Fullerton, Calif.).
Nucleotide sequence accession numbers.
The nucleotide sequences of the 396-bp PCR products from 27 F. psychrophilum isolates were determined and deposited in the DDBJ, EMBL, and GenBank nucleotide sequence databases under the accession numbers listed in Table 1.
|
|
|---|
PCR amplification and sequences of PCR products.
The degenerate universal primers, gyrAF and gyrAR, yielded multiple PCR products from three F. psychrophilum isolates (Fig. 1A). The targeted <450-bp DNA fragment of the gyrA gene was expected to exist in these products. After the cloning and transformation of the products, the length of the inserted DNA in each clone was checked by colony-directed PCR, and then appropriate clones were selected and purified. Following sequence analysis of the products, a specific primer pair, GYRA-FP1F and GYRA-FP1R, was designed. The specific primers successfully yielded an expected single 396-bp PCR product from all isolates tested (Fig. 1B).
![]() View larger version (41K): [in a new window] |
FIG. 1. PCR amplification of partial gyrA sequences from F. psychrophilum isolates. Lanes M, molecular size markers (HyperLadder 1; Bioline, London, United Kingdom); lanes 1, 2, and 3, PCR products of the F. psychrophilum type strain (NCIMB1947), FPC814, and FPC840, respectively. (A) Amplification from F. psychrophilum isolates with degenerate universal primers gyrAF and gyrAR. (B) Amplification of the predicted 396-bp fragments (including primers) from F. psychrophilum isolates with specific primers GYRA-FP1F and GYRA-FP1R.
|
![]() View larger version (38K): [in a new window] |
FIG. 2. Alignment of amino acid sequences of GyrA from F. psychrophilum isolates and E. coli K-12 (accession no. X57174). For F. psychrophilum, the dots represent amino acids identical to those of the type strain of F. psychrophilum (NCIMB1947). All of the amino acids from 102 to 172 were identical in F. psychrophilum isolates. For E. coli, the asterisks indicate amino acids different from those of NCIMB1947.
|
|
|
|---|
In the present study, we attempted to verify our hypothesis that variations in the QRDR contribute intrinsic quinolone resistance in F. psychrophilum isolates. We first determined the MICs of NA and OXA for 27 clinical isolates of F. psychrophilum. A PCR approach using the previously reported universal primers gyrAF and gyrAR was employed to amplify a portion of the F. psychrophilum gyrA QRDR. These universal primers have been determined by alignment of several gyrA sequences from various gram-negative and gram-positive bacterial species and correspond to positions 39 to 45 and 173 to 179 of the amino acid sequence of the E. coli GyrA protein (10). Although the gyrA sequences of members of the genus Flavobacterium have not yet been reported and were not used for designing the primers gyrAF and gyrAR, these universal primers were able to amplify the gyrA region of F. psychrophilum. This indicates that positions 39 to 45 and 173 to 179 of GyrA are regions conserved among many bacterial species, including F. psychrophilum. On the basis of the determined DNA sequences of gyrA amplified with the universal primers, we designed successful primers specific for gyrA of F. psychrophilum (PSY-G1F and PSY-G1R) and determined the nucleotide sequences of all the isolates tested. With a preliminary experiment, the specificity of these primers for F. psychrophilum was confirmed using other bacteria belonging to the genus Flavobacterium (data not shown). This suggests the feasibility of using these primers for PCR detection and identification in F. psychrophilum.
The MICs of quinolones and GyrA substitutions were clearly associated with each other. F. psychrophilum isolates whose GyrA amino acid sequences were equivalent to that of the type strain of F. psychrophilum were susceptible to NA and OXA in the ranges of 0.1 to 3.13 and 0.1 to 0.78 µg/ml, respectively, while isolates possessing GyrA mutations different from the type strain of F. psychrophilum (Thr83-Ala or Ile and Asp87-Tyr) were resistant to both NA and OXA (Table 1). It is known that, in other bacteria, the amino acid substitution(s) at position(s) 83 and/or 87 in GyrA is responsible for quinolone resistance (12, 15). These data strongly indicate that in F. psychrophilum as well, the QRDR in GyrA is an important target for quinolones. In vitro mutagenesis experiments at positions 83 and 87 in GyrA are needed to verify the reasonable hypothesis that QRDR is a target of quinolones in F. psychrophilum.
Bruun et al. reported that F. psychrophilum isolates for which the MICs were <1 µg/ml should be susceptible to OXA, depending on the maximum serum drug concentration obtained in rainbow trout after OXA treatment (3). This assumption for susceptible MICs of OXA in F. psychrophilum is closely matched by our results. In this study, F. psychrophilum isolates for which the MICs ranged from 0.1 to 0.78 µg/ml were susceptible to OXA and possessed GyrA amino acid substitutions compared to the type strain of F. psychrophilum, while isolates for which the MICs ranged from 1.56 to 12.5 µg/ml were resistant. Among the F. psychrophilum isolates from ayu, 11 out of 12 were resistant to NA and OXA. This significantly higher rate of isolates resistant to quinolones may correlate with the previous situation for use of antibiotics in ayu farming: in previous epidemic vibriosis in ayu caused by Listonella anguillara (formerly Vibrio anguillarum), OXA was widely used as a "wonder drug " for the disease in Japan (11, 13). Further investigations are needed to clarify the relationship between antibiotic treatments in fish farming and the appearance of antibiotic-resistant bacteria.
Studies of bacterial mechanisms of quinolone resistance involving DNA gyrase and/or topoisomerase IV mutations have been done since the 1970s, and it has been revealed that many bacteria pathogenic to humans or domestic animals behave the same way in resisting quinolones (12, 15). In the case of fish disease treatments, quinolone antibiotics, such as OXA, have been commonly used in most fish farms or hatcheries, and a study of the quinolone resistance mechanism of Yersinia ruckeri, which causes enteric redmouth disease in salmonid fishs, was recently reported (5). However, this kind of study of bacteria pathogenic to fish is not sufficient. In this study, we explained the quinolone resistance mechanism of F. psychrophilum, and the present study is the first investigation of Flavobacterium species. When antibiotic treatments of cultured fish are done, immersion treatment is more convenient than feeding treatment with drugs intermixed with food, especially in freshwater fish species, such as ayu. Immersion treatment of cultured fish with antibiotics might pose a risk that the targeted pathogenic bacteria, as well as other bacteria naturally inhabiting the water, will acquire resistance to the antibiotics. Because selective pressure caused by the excessive dosage of antibiotics is a common factor in creating antibiotic-resistant strains of bacteria, studies of the antibiotic resistance of bacteria pathogenic to aquatic animals are needed for aquaculture management and the ecological study of aquatic microorganisms.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»